NZ516133A - Alpha substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase - Google Patents

Alpha substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase

Info

Publication number
NZ516133A
NZ516133A NZ516133A NZ51613398A NZ516133A NZ 516133 A NZ516133 A NZ 516133A NZ 516133 A NZ516133 A NZ 516133A NZ 51613398 A NZ51613398 A NZ 51613398A NZ 516133 A NZ516133 A NZ 516133A
Authority
NZ
New Zealand
Prior art keywords
thioalkyl
formula
group
inhibitors
reverse transcriptase
Prior art date
Application number
NZ516133A
Inventor
Supplied Not
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority claimed from NZ503586A external-priority patent/NZ503586A/en
Publication of NZ516133A publication Critical patent/NZ516133A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

6-thioalkyl pyrimidine-2-thioalkyl and alkylether compounds of Formula (I) are disclosed, wherein: M is 0 or 1, and R1 is selected from the group consisting of -CCH, -CO2R53, -CONR54R55, formula (II), formula (III) and formula (IV), and R12 is selected from the group consisting of -H, C1-C6 alkyl, -C3-C6 cycloalkyl, -CN, -C(O)NH2, -C(O)N(C1-C6alkyl)(C1-C6alkyl), -CO2H, -CO2(C1-C6alkyl), -CH2OH, -CH2NH2 or -CF3, and R13 is selected from the group consisting of -H, C1-C6 alkyl or -CF3, and Y is selected from -S, -S(O)-, -S(O)2, or -O-, and R4 is selected from the group consisting of -H, -OH, halo or -NR15R16 where R15 is -H and R16 is -H, C1-C6 alkyl, -NH2 or R15 and R16 taken together with the -N form 1-pyrrolodino, 4-morpholino or 1-piperidino, and R5 is selected from the group consisting of -H, -C2H4OH, -C2H4-O-TBDMS, halo, -C3-C6 cycloalkyl, C1-C4 alkyl or C1-C3 alkoxy. The compounds of Formula (I) are useful in the treatment of individuals who are HIV positive.
NZ516133A 1997-09-25 1998-09-21 Alpha substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase NZ516133A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5965697P 1997-09-25 1997-09-25
NZ503586A NZ503586A (en) 1997-09-25 1998-09-21 Thioalkyl alpha substituted pyrimidine compounds for treating HIV.

Publications (1)

Publication Number Publication Date
NZ516133A true NZ516133A (en) 2003-08-29

Family

ID=27767272

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ516133A NZ516133A (en) 1997-09-25 1998-09-21 Alpha substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase

Country Status (1)

Country Link
NZ (1) NZ516133A (en)

Similar Documents

Publication Publication Date Title
NZ503586A (en) Thioalkyl alpha substituted pyrimidine compounds for treating HIV.
HK1009446A1 (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
KR970707069A (en) SUBITITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOROTEASE INHIBITORS substituted with matrix metal protease inhibitor
PT98064A (en) METHOD FOR PREPARING NEW ANTI-EPILEPTIC COMPOUNDS, NAMES OF N-SUBSTITUTED AMINOALCANOFOSFINIC ACIDS
DE60137540D1 (en) METHODS OF TREATING ANXIETY STATE
BR9506633A (en) Polyurethane resins processes for their preparation and use in water-dilutable coating compositions
DE69430988D1 (en) PYRAZOLOTRIAZINE WITH INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR INHIBITOR EFFECT
NZ531493A (en) Novel depsipeptides and process for preparing same, useful in the treatment of bacterial infection
CA2013599A1 (en) Aryl-substituted rhodanine derivatives
NZ516133A (en) Alpha substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
FI945654A (en) Salts of desferrioxamine-B and their use as orally active iron chelators
ATE150448T1 (en) ORNITHINE DECARBOXYLASE INHIBITING CYCLIC AMINOOXY COMPOUNDS
BR9307288A (en) Compound process for the preparation of the same herbicidal composition and process to combat the growth of undesirable vegetables in a place
SE9402241D0 (en) Inhibitor
AU5653696A (en) Cycloalkane-based cleaning agent
GB9304632D0 (en) Amide derivatives
DE59310218D1 (en) INHIBITORS OF RETROVIRAL PROTEASES
TH13844EX (en) "Benzosacinone as an HIV reverse transcriptase inhibitor"
UA37622A (en) 1.5-piperidil - 3.7 bis/diethanolamine / pirimidil isovaleriant used for diagnostics of virus infections

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed